\-\ Texto\\:\\ \ \(0\)\
\-\ visual\\ acuity\\:\\	\\	\\	right\\ 20\\/25\\ and\\ left\\ 20\\/20\ \(0\)\
\-\ heent\\:\\	\\	\\	\\	\ \(0\)\
\-\ pupils\\ round\\ and\\ reactive\\,\\ \ \(0\)\
\-\ no\\ papilledema\ \(2\)\
\-\ slit\\ lamp\\ exam\\ was\\ within\\ normal\\ limits\ \(0\)\
\-\ left\\ extraocular\\ muscles\\ intact\ \(0\)\
\-\ right\\ eye\\ unable\\ to\\ look\\ superiorly\\ or\\ laterally\\,\\ limited\\ ability\\ to\\ look\\ medially\\ \ \(0\)\
\-\ numbness\\ of\\ the\\ cornea\ \(0\)\
\-\ ptosis\\ with\\ minimal\\ redness\ \(0\)\
\-\ high\\ dose\\ steroids\ \(5\)\
\-\ image\\ 1\\ \\â\\€\\“\\ axial\\ nect\\:\\ \\ subtle\\ soft\\ tissue\\ density\\ right\\ parasellar\\ region\ \(0\)\
\-\ image\\ 2\\ \\â\\€\\“\\ axial\\ cect\\:\\ \\ the\\ cavernous\\ sinus\\ is\\ distended\\ on\\ the\\ right\\ with\\ irregular\\ enhancement\\ of\\ parasellar\\ density\ \(0\)\
\-\ image\\ 3\\ \\â\\€\\“\\ axial\\ fat\\ saturation\\ t1wi\\:\\ isointense\\ extra\\-axial\\ lesion\\ right\\ parasellar\\ region\\,\\ appears\\ to\\ encase\\ cavernous\\ carotids\\;\\ left\\ sinus\\ disease\ \(0\)\
\-\ image\\ 4\\ \\â\\€\\“\\ axial\\ t2wi\\:\\ slight\\ hyperintense\\ extra\\-axial\\ lesion\\ right\\ cavernous\\ sinus\\;\\ left\\ sinus\\ disease\ \(0\)\
\-\ image\\ 5\\ \\â\\€\\“\\ mra\\:\\ normal\\ mra\\ without\\ definite\\ carotid\\ involvement\\ \ \(0\)\
\-\ image\\ 6\\ \\â\\€\\“\\ sagittal\\ t1wi\\+\\:\\ diffuse\\ enhancement\\ of\\ lesion\ \(0\)\
\-\ image\\ 7\\ \\â\\€\\“\\ axial\\ flair\\ t1wi\\+\\:\\ diffuse\\ enhancement\\ of\\ lesion\ \(0\)\
\-\ tolosa\\ hunt\ \(0\)\
\-\ inflammation\\,\\ neoplasm\\ \\(meningioma\\,\\ craniopharyngioma\\,\\ pituitary\\ adenoma\\)\\,\\ metastasis\\,\\ infection\\ \\(meningitis\\,\\ sarcoidosis\\,\\ actinomycosis\\)\\,\\ meningeal\\ non\\-hodgkin\\ lymphoma\\,\\ trauma\\,\\ aneurysm\\ or\\ carotid\\ cavernous\\ fistula\ \(0\)\
\-\ patient\\ is\\ a\\ 10\\ year\\ old\\ female\\ initially\\ seen\\ by\\ the\\ pcp\\ for\\ nausea\\,\\ vomiting\\,\\ and\\ headache\\ over\\ the\\ right\\ orbital\\/temporal\\ region\\.\\ her\\ symptoms\\ were\\ initially\\ attributed\\ to\\ sinus\\ disease\\ for\\ which\\ she\\ began\\ a\\ course\\ of\\ amoxicillin\\.\\ her\\ symptoms\\ did\\ not\\ improve\\ and\\ she\\ was\\ switched\\ to\\ cefuroxime\\.\\ \\ she\\ was\\ then\\ seen\\ again\\ by\\ the\\ pcp\\ due\\ to\\ worsening\\ headache\\,\\ right\\ eye\\ pain\\,\\ and\\ worsening\\ intermittent\\ double\\ vision\\ over\\ the\\ last\\ month\\,\\ more\\ noticeably\\ within\\ the\\ last\\ week\\.\\ she\\ was\\ then\\ referred\\ to\\ the\\ ophthalmology\\ clinic\\ for\\ ophthalmoplegia\\ and\\ inability\\ to\\ fully\\ elevate\\ the\\ right\\ eyelid\\.\ \(0\)\
\-\ in\\ this\\ patient\\,\\ the\\ inability\\ to\\ look\\ superiorly\\ is\\ due\\ to\\ involvement\\ of\\ cn\\ iv\\.\\ the\\ trochlear\\ nerve\\ innervates\\ the\\ superior\\ oblique\\ muscle\\.\\ \\ cn\\ vi\\ involvement\\ is\\ demonstrated\\ with\\ the\\ inability\\ to\\ gaze\\ laterally\\.\\ \\ the\\ abducens\\ nerve\\ innervates\\ the\\ lateral\\ rectus\\ muscle\\ allowing\\ for\\ lateral\\ gaze\\.\\ \\ cn\\ iii\\ involvement\\ seen\\ with\\ ptosis\\.\\ the\\ eyelids\\ are\\ elevated\\ by\\ the\\ contraction\\ of\\ the\\ levator\\ palpebrae\\ superioris\\ which\\ is\\ innervated\\ by\\ cniii\\.\\ \\ cn\\ v1\\ involvement\\ resulted\\ in\\ loss\\ of\\ corneal\\ reflex\\ as\\ it\\ provides\\ the\\ sensory\\ fibers\\ to\\ the\\ eye\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ image\\:\\ 0\\.22115506219736872\ \(0\)\
\-\ the\\:\\ 0\\.20700193480805507\ \(0\)\
\-\ parasellar\\:\\ 0\\.2009909398729553\ \(0\)\
\-\ axial\\:\\ 0\\.1997494536740625\ \(0\)\
\-\ cn\\:\\ 0\\.19285047645492995\ \(0\)\
\-\ involvement\\:\\ 0\\.17877572682110462\ \(0\)\
\-\ sinus\\:\\ 0\\.17848315259874906\ \(0\)\
\-\ cavernous\\:\\ 0\\.17140655210164055\ \(0\)\
\-\ t1wi\\:\\ 0\\.16191426894487035\ \(0\)\
\-\ inability\\:\\ 0\\.15286508962528197\ \(0\)\
\-\ innervates\\:\\ 0\\.1509822443563068\ \(0\)\
\-\ look\\:\\ 0\\.1490794250656825\ \(0\)\
\-\ to\\:\\ 0\\.14820101557350482\ \(0\)\
\-\ right\\:\\ 0\\.14740546400555665\ \(0\)\
\-\ ptosis\\:\\ 0\\.119011920519925\ \(0\)\
\-\ eye\\:\\ 0\\.11855920610750706\ \(0\)\
\-\ she\\:\\ 0\\.11762830252872587\ \(0\)\
\-\ gaze\\:\\ 0\\.11647270025099092\ \(0\)\
\-\ pcp\\:\\ 0\\.11053278465222358\ \(0\)\
\-\ laterally\\:\\ 0\\.09998359526049037\ \(0\)\
\-\ superiorly\\:\\ 0\\.09938628337712167\ \(0\)\
\-\ mra\\:\\ 0\\.0977088126176329\ \(0\)\
\-\ lesion\\:\\ 0\\.09473522927562761\ \(0\)\
\-\ region\\:\\ 0\\.08864784554813859\ \(0\)\
\-\ enhancement\\:\\ 0\\.08530259493541922\ \(0\)\
\-\ by\\:\\ 0\\.08391365464054648\ \(0\)\
\-\ carotid\\:\\ 0\\.08322472249213451\ \(0\)\
\-\ last\\:\\ 0\\.08035795811768703\ \(0\)\
\-\ superioris\\:\\ 0\\.0790025165244644\ \(0\)\
\-\ cniii\\:\\ 0\\.0790025165244644\ \(0\)\
\-\ initially\\:\\ 0\\.0774795877219871\ \(0\)\
\-\ of\\:\\ 0\\.07734002841979327\ \(0\)\
\-\ palpebrae\\:\\ 0\\.0754911221781534\ \(0\)\
\-\ worsening\\:\\ 0\\.07544875739463593\ \(0\)\
\-\ slit\\:\\ 0\\.07299974824105808\ \(0\)\
\-\ lamp\\:\\ 0\\.07299974824105808\ \(0\)\
\-\ cefuroxime\\:\\ 0\\.07299974824105808\ \(0\)\
\-\ noticeably\\:\\ 0\\.07299974824105808\ \(0\)\
\-\ trochlear\\:\\ 0\\.07299974824105808\ \(0\)\
\-\ ophthalmoplegia\\:\\ 0\\.0710672884835308\ \(0\)\
\-\ elevate\\:\\ 0\\.0710672884835308\ \(0\)\
\-\ nerve\\:\\ 0\\.07048444520932597\ \(0\)\
\-\ muscle\\:\\ 0\\.07015556833991865\ \(0\)\
\-\ then\\:\\ 0\\.0699397359138062\ \(0\)\
\-\ seen\\:\\ 0\\.06977238639319018\ \(0\)\
\-\ tolosa\\:\\ 0\\.06948835389474708\ \(0\)\
\-\ innervated\\:\\ 0\\.06948835389474708\ \(0\)\
\-\ was\\:\\ 0\\.06886656934687371\ \(0\)\
\-\ cornea\\:\\ 0\\.06815338372147872\ \(0\)\
\-\ encase\\:\\ 0\\.06815338372147872\ \(0\)\
\-\ headache\\:\\ 0\\.06810949571642261\ \(0\)\
\-\ is\\:\\ 0\\.06764362314556958\ \(0\)\
\-\ left\\:\\ 0\\.06740666119692026\ \(0\)\
\-\ nect\\:\\ 0\\.06699697995765178\ \(0\)\
\-\ actinomycosis\\:\\ 0\\.06597695954843608\ \(0\)\
\-\ amoxicillin\\:\\ 0\\.06597695954843608\ \(0\)\
\-\ abducens\\:\\ 0\\.06597695954843608\ \(0\)\
\-\ levator\\:\\ 0\\.06597695954843608\ \(0\)\
\-\ density\\:\\ 0\\.06551553699074036\ \(0\)\
\-\ hunt\\:\\ 0\\.06506452020012449\ \(0\)\
\-\ eyelids\\:\\ 0\\.06506452020012449\ \(0\)\
\-\ switched\\:\\ 0\\.06423911840890177\ \(0\)\
\-\ v1\\:\\ 0\\.06348558561134077\ \(0\)\
\-\ corneal\\:\\ 0\\.06279240263315636\ \(0\)\
\-\ disease\\:\\ 0\\.062210010252710966\ \(0\)\
\-\ contraction\\:\\ 0\\.062150615438072404\ \(0\)\
\-\ diffuse\\:\\ 0\\.06196074051442773\ \(0\)\
\-\ her\\:\\ 0\\.061725543308756695\ \(0\)\
\-\ cect\\:\\ 0\\.06155312585381349\ \(0\)\
\-\ carotids\\:\\ 0\\.06155312585381349\ \(0\)\
\-\ and\\:\\ 0\\.061248332140319973\ \(0\)\
\-\ eyelid\\:\\ 0\\.060469192504811316\ \(0\)\
\-\ for\\:\\ 0\\.05989192448295274\ \(0\)\
\-\ ophthalmology\\:\\ 0\\.05823635012549546\ \(0\)\
\-\ redness\\:\\ 0\\.057129292159190895\ \(0\)\
\-\ due\\:\\ 0\\.05679292666512939\ \(0\)\
\-\ vi\\:\\ 0\\.05646279691871877\ \(0\)\
\-\ allowing\\:\\ 0\\.056147847154666086\ \(0\)\
\-\ meningeal\\:\\ 0\\.05555035757040717\ \(0\)\
\-\ attributed\\:\\ 0\\.05526639232611179\ \(0\)\
\-\ acuity\\:\\ 0\\.05499144339083913\ \(0\)\
\-\ over\\:\\ 0\\.054937951821805726\ \(0\)\
\-\ papilledema\\:\\ 0\\.054466424221405\ \(0\)\
\-\ provides\\:\\ 0\\.05421538739713881\ \(0\)\
\-\ symptoms\\:\\ 0\\.05405855848955509\ \(0\)\
\-\ extraocular\\:\\ 0\\.05373414337078897\ \(0\)\
\-\ ability\\:\\ 0\\.05350319197655618\ \(0\)\
\-\ fully\\:\\ 0\\.05327824000343904\ \(0\)\
\-\ t2wi\\:\\ 0\\.052845141557849355\ \(0\)\
\-\ saturation\\:\\ 0\\.05130148263508672\ \(0\)\
\-\ rectus\\:\\ 0\\.05112652387578458\ \(0\)\
\-\ medially\\:\\ 0\\.05046002863531245\ \(0\)\
\-\ resulted\\:\\ 0\\.05030112208456186\ \(0\)\
\-\ fibers\\:\\ 0\\.04999179763024519\ \(0\)\
\-\ lateral\\:\\ 0\\.04903299148831979\ \(0\)\
\-\ pupils\\:\\ 0\\.048988675107432815\ \(0\)\
\-\ reflex\\:\\ 0\\.04885440630881645\ \(0\)\
\-\ definite\\:\\ 0\\.0485919570110769\ \(0\)\
\-\ improve\\:\\ 0\\.047968654698217136\ \(0\)\
\-\ craniopharyngioma\\:\\ 0\\.04773137508738265\ \(0\)\
\-\ meningitis\\:\\ 0\\.0465311961804714\ \(0\)\
\-\ sensory\\:\\ 0\\.0465311961804714\ \(0\)\
\-\ dose\\:\\ 0\\.046132957556671655\ \(0\)\
\-\ began\\:\\ 0\\.04594050154676436\ \(0\)\
\-\ pituitary\\:\\ 0\\.04556796393562258\ \(0\)\
\-\ within\\:\\ 0\\.04550490273033409\ \(0\)\
\-\ which\\:\\ 0\\.04492600386741442\ \(0\)\
\-\ isointense\\:\\ 0\\.044701224767421485\ \(0\)\
\-\ fistula\\:\\ 0\\.04461913728993813\ \(0\)\
\-\ heent\\:\\ 0\\.04414231058785345\ \(0\)\
\-\ again\\:\\ 0\\.04406533084512983\ \(0\)\
\-\ numbness\\:\\ 0\\.04391339424568833\ \(0\)\
\-\ double\\:\\ 0\\.04354482100359453\ \(0\)\
\-\ steroids\\:\\ 0\\.04340167453732829\ \(0\)\
\-\ slight\\:\\ 0\\.04326085575929915\ \(0\)\
\-\ unable\\:\\ 0\\.04278527629046125\ \(0\)\
\-\ vision\\:\\ 0\\.04278527629046125\ \(0\)\
\-\ oblique\\:\\ 0\\.04278527629046125\ \(0\)\
\-\ iii\\:\\ 0\\.0426540591735705\ \(0\)\
\-\ subtle\\:\\ 0\\.04258918872767059\ \(0\)\
\-\ reactive\\:\\ 0\\.042397442945674796\ \(0\)\
\-\ muscles\\:\\ 0\\.042334459656904605\ \(0\)\
\-\ distended\\:\\ 0\\.04220985083032617\ \(0\)\
\-\ visual\\:\\ 0\\.04214821239194057\ \(0\)\
\-\ flair\\:\\ 0\\.042026236234187414\ \(0\)\
\-\ sarcoidosis\\:\\ 0\\.04184643398256993\ \(0\)\
\-\ clinic\\:\\ 0\\.04161236124606726\ \(0\)\
\-\ round\\:\\ 0\\.04047763500052787\ \(0\)\
\-\ intermittent\\:\\ 0\\.04037693428409567\ \(0\)\
\-\ normal\\:\\ 0\\.04033997091276529\ \(0\)\
\-\ inflammation\\:\\ 0\\.039703026105842365\ \(0\)\
\-\ limited\\:\\ 0\\.039429524511432786\ \(0\)\
\-\ adenoma\\:\\ 0\\.039384769042137474\ \(0\)\
\-\ hyperintense\\:\\ 0\\.039295946068274086\ \(0\)\
\-\ limits\\:\\ 0\\.039034815811590184\ \(0\)\
\-\ with\\:\\ 0\\.038693119534172496\ \(0\)\
\-\ irregular\\:\\ 0\\.03813954230444713\ \(0\)\
\-\ sagittal\\:\\ 0\\.03798626106343255\ \(0\)\
\-\ nausea\\:\\ 0\\.03794836094152373\ \(0\)\
\-\ minimal\\:\\ 0\\.0376876051217482\ \(0\)\
\-\ aneurysm\\:\\ 0\\.037614523135013\ \(0\)\
\-\ meningioma\\:\\ 0\\.03701703355075408\ \(0\)\
\-\ vomiting\\:\\ 0\\.036554166537208\ \(0\)\
\-\ referred\\:\\ 0\\.036554166537208\ \(0\)\
\-\ course\\:\\ 0\\.03649001688066892\ \(0\)\
\-\ metastasis\\:\\ 0\\.03620708254691985\ \(0\)\
\-\ appears\\:\\ 0\\.036176208489142984\ \(0\)\
\-\ intact\\:\\ 0\\.03575514536422092\ \(0\)\
\-\ did\\:\\ 0\\.03543809896197035\ \(0\)\
\-\ iv\\:\\ 0\\.03529773666677264\ \(0\)\
\-\ or\\:\\ 0\\.03437126632485374\ \(0\)\
\-\ neoplasm\\:\\ 0\\.03372344435311164\ \(0\)\
\-\ elevated\\:\\ 0\\.033677133205133665\ \(0\)\
\-\ week\\:\\ 0\\.03322715334282595\ \(0\)\
\-\ patient\\:\\ 0\\.032135152830223584\ \(0\)\
\-\ superior\\:\\ 0\\.03211746484016721\ \(0\)\
\-\ fat\\:\\ 0\\.030730300023052375\ \(0\)\
\-\ demonstrated\\:\\ 0\\.03036035747681563\ \(0\)\
\-\ loss\\:\\ 0\\.030096733202609444\ \(0\)\
\-\ month\\:\\ 0\\.030051033022498952\ \(0\)\
\-\ infection\\:\\ 0\\.029840897415757302\ \(0\)\
\-\ lymphoma\\:\\ 0\\.029421191632102398\ \(0\)\
\-\ 10\\:\\ 0\\.028887035953464726\ \(0\)\
\-\ trauma\\:\\ 0\\.028690056331085793\ \(0\)\
\-\ high\\:\\ 0\\.028076136254440408\ \(0\)\
\-\ more\\:\\ 0\\.02712628271859847\ \(0\)\
\-\ soft\\:\\ 0\\.02629989564220101\ \(0\)\
\-\ without\\:\\ 0\\.02605702599491087\ \(0\)\
\-\ tissue\\:\\ 0\\.025914507736837133\ \(0\)\
\-\ were\\:\\ 0\\.02546464715971387\ \(0\)\
\-\ it\\:\\ 0\\.025287541518435507\ \(0\)\
\-\ exam\\:\\ 0\\.024868350517675192\ \(0\)\
\-\ in\\:\\ 0\\.024578595080297815\ \(0\)\
\-\ female\\:\\ 0\\.023838129132350984\ \(0\)\
\-\ as\\:\\ 0\\.019846025156286164\ \(0\)\
\-\ not\\:\\ 0\\.019502231771636513\ \(0\)\
\-\ are\\:\\ 0\\.018745329041858102\ \(0\)\
\-\ pain\\:\\ 0\\.017677398016302918\ \(0\)\
\-\ this\\:\\ 0\\.016974979320109537\ \(0\)\
\-\ no\\:\\ 0\\.016064554197655165\ \(0\)\
\-\ year\\:\\ 0\\.015224331344347005\ \(0\)\
\-\ on\\:\\ 0\\.014919867406049022\ \(0\)\
\-\ old\\:\\ 0\\.014620628123652144\ \(0\)\
